KDM1A and acute myeloid leukemia: We expect that in the near future a deeper characterization of the molecular functions of LSD1 in leukemia along with the results of these first clinical studies will result in clearer understanding of epigenetic regulatory mechanisms in AML and improved treatment of patients.